These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30426509)

  • 21. Prediagnostic level of serum retinol in relation to reduced risk of hepatocellular carcinoma.
    Yuan JM; Gao YT; Ong CN; Ross RK; Yu MC
    J Natl Cancer Inst; 2006 Apr; 98(7):482-90. PubMed ID: 16595784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
    Lee S; Rhim H; Kim YS; Kang TW; Song KD
    Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron, copper and zinc levels in serum and cirrhotic liver of patients with and without hepatocellular carcinoma.
    Nagasue N; Kolno H; Chang YC; Nakamura T
    Oncology; 1989; 46(5):293-6. PubMed ID: 2550861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D receptor gene polymorphisms, bioavailable 25-hydroxyvitamin D, and hepatocellular carcinoma survival.
    Shu J; Zhang M; Dong X; Long J; Li Y; Tan P; He T; Giovannucci EL; Zhang X; Zhou Z; Xu Y; Xu X; Peng T; Lu J; Chen M; Zhu H; Zhang Y; Fang A
    J Natl Cancer Inst; 2024 Oct; 116(10):1687-1696. PubMed ID: 38830043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma.
    Han X; Gu YK; Li SL; Chen H; Chen MS; Cai QQ; Deng HX; Zuo MX; Huang JH
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):303-312. PubMed ID: 30267213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Epithelial Cell Adhesion Molecule-Positive Circulating Tumor Cell Count Predicts Poor Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization.
    Shen J; Wang WS; Zhu XL; Ni CF
    J Vasc Interv Radiol; 2018 Dec; 29(12):1678-1684. PubMed ID: 30392801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
    Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
    [No Abstract]   [Full Text] [Related]  

  • 28. Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery.
    Zhu CB; Chen LL; Tian JJ; Su L; Wang C; Gai ZT; Du WJ; Ma GL
    Ann Surg Oncol; 2012 Mar; 19(3):817-25. PubMed ID: 21861215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors of spontaneously ruptured hepatocellular carcinoma.
    Han XJ; Su HY; Shao HB; Xu K
    World J Gastroenterol; 2015 Jun; 21(24):7488-94. PubMed ID: 26139994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
    Schulze K; Gasch C; Staufer K; Nashan B; Lohse AW; Pantel K; Riethdorf S; Wege H
    Int J Cancer; 2013 Nov; 133(9):2165-71. PubMed ID: 23616258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modified Glasgow prognostic score might be a prognostic factor for hepatocellular carcinoma: a meta-analysis.
    Chen H; Hu N; Chang P; Kang T; Han S; Lu Y; Li M
    Panminerva Med; 2017 Dec; 59(4):302-307. PubMed ID: 28001023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
    Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
    Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated serum soluble CD14 levels in chronic HBV infection are significantly associated with HBV-related hepatocellular carcinoma.
    Li N; Zhu Q; Yang C; Li F; Zhou Z; Lv Y; Sang J; Han Q; Liu Z
    Tumour Biol; 2016 May; 37(5):6607-17. PubMed ID: 26643893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of the copper/zinc ratio in hepatocellular carcinoma: a case control study.
    Poo JL; Rosas-Romero R; Montemayor AC; Isoard F; Uribe M
    J Gastroenterol; 2003; 38(1):45-51. PubMed ID: 12560921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum copper-to-zinc-ratio and risk of incident infection in men: the Kuopio Ischaemic Heart Disease Risk Factor Study.
    Laine JT; Tuomainen TP; Salonen JT; Virtanen JK
    Eur J Epidemiol; 2020 Dec; 35(12):1149-1156. PubMed ID: 32405672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L; Chu F; Cao Y; Shao J; Wang F
    Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary choline, rather than betaine intake, is associated with hepatocellular carcinoma mortality.
    Liu ZY; Zhang DM; Yishake D; Luo Y; Fang AP; Zhu HL
    Food Funct; 2020 Sep; 11(9):7866-7877. PubMed ID: 32812611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of Copper in Hepatocarcinogenesis via the Activation of Hypoxia-Inducible Factor-1α.
    Himoto T; Fujita K; Nomura T; Tani J; Miyoshi H; Morishita A; Yoneyama H; Kubota S; Haba R; Suzuki Y; Masaki T
    Biol Trace Elem Res; 2016 Nov; 174(1):58-64. PubMed ID: 27121973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib.
    Cho HJ; Kim SS; Nam JS; Oh MJ; Kang DR; Kim JK; Lee JH; Kim B; Yang MJ; Hwang JC; Lim SG; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
    Cytokine; 2017 Jul; 95():118-125. PubMed ID: 28260649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.